563 results on '"Martinez-Sobrido, Luis"'
Search Results
2. Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Catalog
Books, media, physical & digital resources
3. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective
4. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle
5. Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model
6. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
7. Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology
8. Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization
9. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
10. A highly efficacious live attenuated mumps virus—based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
11. SARS-CoV-2 variants evolve convergent strategies to remodel the host response
12. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
13. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2
14. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming
15. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
16. Dung biomass smoke exposure impairs resolution of inflammatory responses to influenza infection
17. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
18. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
19. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
20. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics
21. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
22. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
23. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
24. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
25. Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants
26. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
27. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
28. Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment.
29. Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication.
30. Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.
31. Reverse genetics approaches for the development of mammarenavirus live-attenuated vaccines
32. AGL2017-82570-RReverse genetics approaches for the development of new vaccines against influenza A virus infections
33. Peptides Derived from the Tight Junction Protein CLDN1 Disrupt the Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine
34. Onward transmission of viruses : how do viruses emerge to cause epidemics after spillover?
35. A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity
36. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets
37. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
38. A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide
39. Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
40. Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
41. New Advances on Zika Virus Research.
42. Development of a novel equine influenza virus live-attenuated vaccine
43. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease
44. A live-attenuated influenza vaccine for H3N2 canine influenza virus
45. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
46. Structural basis of RNA cap modification by SARS-CoV-2
47. New Advances on Zika Virus Research
48. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
49. Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virusinfected patients.
50. Editorial for SARS-CoV-2 and COVID-19 Topical Collection.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.